SARS-CoV-2 protease suppresses host immune response by cleaving NEMO

A recent study conducted by a team of US-based scientists has highlighted a novel function of 3C-like protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The protease has been found to cleave a human immune signaling protein called NF-kB Essential Modulator (NEMO) and disrupt the host immune response. The study is currently available on the bioRxiv* preprint server while awaiting peer review.

Background

The non-structural proteins of SARS-CoV-2, including papain-like protease and 3C-like protease, play essential roles in regulating viral lifecycle and disrupting host immune defense. The 3C-like protease recognizes a specific motif in viral polyproteins and cleaves them to form mature non-structural proteins. The same recognition motif is also present in some proteins of the host innate immune pathways. This indicates that 3C-like protease can cleave host proteins to disrupt the first-line antiviral defense mechanism.

In the current study, scientists have investigated whether 3C-like protease has any impact on human immune signaling protein NEMO. During canonical NF-kB response signaling, NEMO cleaves and activates NF-kB, which is an important step for early-stage viral clearance.

NEMO binding to 3C-like protease

The study observed that 3C-like protease interacts with Lys226-His235 of the α-helical Hlx2 domain of one NEMO protomer for cleavage. Thus, as mentioned by the scientists, the protease might utilize a transient state of the α-helical domain for proteolysis. In addition, it might actively outcompete NEMO dimer interactions and unwind the α-helix.

Specifically, 3C-like protease formed hydrophobic interactions and hydrogen bonds with specific residues in the NEMO to outcompete the interactions between these residues in the NEMO dimer.

Structure of the NEMO-bound 3CLpro C145S homodimer. a) Global view of NEMObound 3CLpro dimer. Chains C and D have their N- (NH3+) and C-termini (COO-) labeled. NEMO bound into chain C (NEMO C) is displayed as sticks and colored wheat. A mesh of electron density is displayed around NEMO C in light grey. Acetylated Lys226 and amidated His235 at the N- and C-terminus of the NEMO peptide, respectively, are labeled. The C-terminal tail of chain A is colored in light pink, displayed as sticks and is observed to bind into the substrate-binding site of chain D. Domains I (aa. 8-101), II (aa. 102-184) and III (aa. 201-303) are labeled in black. b) Interactions of NEMO with the substrate-binding groove of 3CLpro C145S. NEMO is depicted in wheat. Residues Lys226 to His235 of NEMO are labeled P6 to P4’, respectively. The surface of chain C is shown in light blue and colored by atom type, where oxygens are red, nitrogens are dark blue, carbons are light blue, and sulfurs are yellow. Residues in the substrate-binding site of chain C are portrayed as lines and labeled. Catalytically relevant residues22 in chain C are portrayed as sticks and also labeled in bold. Hydrogen bonds are depicted as dashed yellow lines. The hydrogen bond that would form between Cys145 (in WT) or Ser145 (in C145S) and His41 is depicted as a dashed green line. c) Interactions of the C-terminal tail of chain A with the substrate-binding groove of 3CLpro C145S. The C-terminal tail of chain A is depicted as sticks in light pink. Residues Ser301 to Gln306 are labeled P6 to P1 respectively. The surface of chain D is shown in teal and colored by atom type. Residues in the substrate-binding groove of chain D that interact with the C-terminal tail of chain A are portrayed as lines and labeled. Catalytically relevant residues and hydrogen bonds are portrayed as in (b). The oxygen atom of water 95 is depicted as a red sphere.
Structure of the NEMO-bound 3CLpro C145S homodimer. a) Global view of NEMObound 3CLpro dimer. Chains C and D have their N- (NH3+) and C-termini (COO-) labeled. NEMO bound into chain C (NEMO C) is displayed as sticks and colored wheat. A mesh of electron density is displayed around NEMO C in light grey. Acetylated Lys226 and amidated His235 at the N- and C-terminus of the NEMO peptide, respectively, are labeled. The C-terminal tail of chain A is colored in light pink, displayed as sticks and is observed to bind into the substrate-binding site of chain D. Domains I (aa. 8-101), II (aa. 102-184) and III (aa. 201-303) are labeled in black. b) Interactions of NEMO with the substrate-binding groove of 3CLpro C145S. NEMO is depicted in wheat. Residues Lys226 to His235 of NEMO are labeled P6 to P4’, respectively. The surface of chain C is shown in light blue and colored by atom type, where oxygens are red, nitrogens are dark blue, carbons are light blue, and sulfurs are yellow. Residues in the substrate-binding site of chain C are portrayed as lines and labeled. Catalytically relevant residues22 in chain C are portrayed as sticks and also labeled in bold. Hydrogen bonds are depicted as dashed yellow lines. The hydrogen bond that would form between Cys145 (in WT) or Ser145 (in C145S) and His41 is depicted as a dashed green line. c) Interactions of the C-terminal tail of chain A with the substrate-binding groove of 3CLpro C145S. The C-terminal tail of chain A is depicted as sticks in light pink. Residues Ser301 to Gln306 are labeled P6 to P1 respectively. The surface of chain D is shown in teal and colored by atom type. Residues in the substrate-binding groove of chain D that interact with the C-terminal tail of chain A are portrayed as lines and labeled. Catalytically relevant residues and hydrogen bonds are portrayed as in (b). The oxygen atom of water 95 is depicted as a red sphere.

Substrate-selectivity of 3C-like protease

The study identified specific subsites that contribute to the substrate versatility of 3C-like protease. Specific interactions of 3C-like protease with its N-terminal autoprocessing sequence or NEMO substrate were identified.

The findings revealed that the S1 subsite is flexible and binds to the NEMO substrate through hydrophobic interactions. However, this subsite did not interact with the N-terminal substrate. In contrast, the S5 subsite interacted with the N-terminal substrate by recruiting a water molecule.

The interactions of S2 subsite with N-terminal and NEMO substrates were found to be conserved. However, the S3 and S4 subsites were identified as significant contributors to substrate versatility.

The findings of the computational analysis revealed that the single substitution S46A in the substrate-binding site of 3C-like protease increases local rigidity, leading to a reduction in NEMO affinity. Similarly, it was predicted that another substitution mutation V232A in NEMO can impair its interaction with 3C-like protease.  

Functional consequences of 3C-like protease – NEMO interaction

The enzymatic assay findings revealed that cleavage of NEMO by 3C-like protease is a slow process and does not have a significant functional impact in the initial hours of infection. Moreover, it has been observed in other studies that SARS-CoV-2 proteases cleave multiple host proteins, leading to a significant reduction in protein levels within 24 – 48 of infection.

Overall, these findings indicate that 3C-like protease-mediated cleavage of NEMO is a part of various other mechanisms that are triggered by SARS-CoV-2 to suppress host immune responses.  

Given the clinical similarities between NEMO ablation and COVID-19, it could be considered that 3C-like protease-mediated cleavage of NEMO plays a significant role in COVID-19 pathophysiology.

Study significance

The study identifies the role of SARS-CoV-2 3C-like protease in cleaving host immune protein NEMO. It is known that NEMO plays a central role in the mitochondrial antiviral-signaling protein-mediated antiviral immune response. Furthermore, ablation of NEMO is known to cause the inactivation of NF-kB and type 1 interferon response.

Given these observations, the scientists suggest that 3C-like protease can be considered as a potential therapeutic target for preventing virus-induced host immunosuppression as well as viral replication.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2021, November 16). SARS-CoV-2 protease suppresses host immune response by cleaving NEMO. News-Medical. Retrieved on October 04, 2024 from https://www.news-medical.net/news/20211116/SARS-CoV-2-protease-suppresses-host-immune-response-by-cleaving-NEMO.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "SARS-CoV-2 protease suppresses host immune response by cleaving NEMO". News-Medical. 04 October 2024. <https://www.news-medical.net/news/20211116/SARS-CoV-2-protease-suppresses-host-immune-response-by-cleaving-NEMO.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "SARS-CoV-2 protease suppresses host immune response by cleaving NEMO". News-Medical. https://www.news-medical.net/news/20211116/SARS-CoV-2-protease-suppresses-host-immune-response-by-cleaving-NEMO.aspx. (accessed October 04, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2021. SARS-CoV-2 protease suppresses host immune response by cleaving NEMO. News-Medical, viewed 04 October 2024, https://www.news-medical.net/news/20211116/SARS-CoV-2-protease-suppresses-host-immune-response-by-cleaving-NEMO.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2